EichorEICHOR
Condition: Metastatic Liver Cancers Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Metastatic Liver Cancers

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases
Phase 1 · 1 location(s) · Changhai Hospital · NCT05240950Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
NA · 13 location(s) · Imperial College London · NCT02246634CapTemY90 for Grade 2/3 NET Liver Metastases
Phase 2 · 4 location(s) · Abramson Cancer Center at Penn Medicine · NCT04339036Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
Phase N/A · 1 location(s) · Palo Alto Veterans Institute for Research · NCT07303712SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT03452774SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05775146Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Brea
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT07284836Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer
Phase 2 · 1 location(s) · Shanghai Changzheng Hospital · NCT07398326MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
Phase N/A · 1 location(s) · Shengjing Hospital · NCT06208397FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype
NA · 1 location(s) · UMC Utrecht · NCT06191120Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NA · 2 location(s) · University of California, San Francisco · NCT04221893Streamlining Radioembolization for CCC and Metastatic Liver Cancer
Phase N/A · 4 location(s) · Seoul National University Hospital · NCT07043387- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Misma
Phase 2 · 23 location(s) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06856837A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
NA · 1 location(s) · Ruijin Hospital · NCT06567353Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224724Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
NA · 6 location(s) · Anhui Provincial Hospital · NCT06449937TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery
NA · 1 location(s) · Medical University of Warsaw · NCT06050200On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Phase N/A · 2 location(s) · Region Skane · NCT05755672IDOV-Immune for Advanced Solid Tumors
Phase 1 · 5 location(s) · ViroMissile, Inc. · NCT06910657A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Phase 2 · 76 location(s) · AstraZeneca · NCT06792695Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
Phase N/A · 1 location(s) · Tongji Hospital · NCT07587216Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOO
Phase N/A · 30 location(s) · HistoSonics, Inc. · NCT06486454Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver
NA · 1 location(s) · Warangkana Lapisatepun · NCT06905015COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Per
Phase 2/Phase 3 · 1 location(s) · Amsterdam UMC, location VUmc · NCT06185556Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metasta
Phase 1/Phase 2 · 4 location(s) · National Cancer Institute (NCI) · NCT06811116Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06066333Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver
Phase 2 · 1 location(s) · Azienda Ospedaliera di Padova · NCT06690528A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves T
Phase 1 · 11 location(s) · AbbVie · NCT06487559Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer
NA · 1 location(s) · Fudan University · NCT06934018
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.